Back
Better Management of Adverse Events Favors Sorafenib Treatment of HCC Patients and Impact on Survival
Regiane S. S. M. Alencar, Luciana Kikuchi, Cláudia M. Tani, Aline L. Chagas, Cinira C. Camargo, Túlio E. F. Pfiffer, Paulo M. G. Hoff, Flair J. Carrilho
J. Cancer Ther. Vol.7 No.4, April 22, 2016  DOI: 10.4236/jct.2016.74029
       (PDF  636K)     HTML      XML
Gender Effects on Statin-Associated Muscular Adverse Events: An Analysis of the FDA AERS Database
Hiroyuki Murakami, Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
Pharmacol. Pharm. Vol.4 No.3, June 20, 2013  DOI: 10.4236/pp.2013.43049
       (PDF  142K)     HTML     
Efficacy and Safety of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma
Takahito Suyama, Takeshi Ueda, Satoshi Fukasawa, Atsushi Komaru, Masayuki Kobayashi, Yukio Naya, Naoki Nihei, Tomohiko Ichikawa
J. Cancer Ther. Vol.2 No.3, August 24, 2011  DOI: 10.4236/jct.2011.23046
       (PDF  663K)     HTML     
Severe Allergic Reaction to Oral Artesunate-Amodiaquine Combination Treatment for Malaria: Case Report in the Democratic Republic of Congo
Edouard Kawawa Swana, Christian Katshiza, Oscar Numbi Luboya, Michael J. Bangs
OALIBJ Vol.4 No.6, June 09, 2017  DOI: 10.4236/oalib.1103676
       (PDF  313K)     HTML      XML
The Association between Serum Resistin Levels and Major Adverse Cardiac Events
Umit Yasar Sinan, Ozge Cetinarslan, Veysel Oktay, Ilknur Calpar, Yalcin Dalgic, Aysem Kaya, Alev Arat Ozkan, Murat K. Ersanli
World J. Cardiovasc. Dis. Vol.7 No.10, October 19, 2017  DOI: 10.4236/wjcd.2017.710031
       (PDF  288K)     HTML      XML
 
 
Top